RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+33.91%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$164B
AUM Growth
+$11.8B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
4,090
New
Increased
Reduced
Closed

Top Sells

1 +$516M
2 +$512M
3 +$348M
4
AAPL icon
Apple
AAPL
+$162M
5
DVN icon
Devon Energy
DVN
+$142M

Sector Composition

1 Technology 16.27%
2 Financials 8.93%
3 Healthcare 7.98%
4 Industrials 6.58%
5 Consumer Discretionary 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMU
3876
MFS High Yield Municipal Trust
CMU
$85.7M
-11,415
EWS icon
3877
iShares MSCI Singapore ETF
EWS
$850M
-10,475
EXK
3878
Endeavour Silver
EXK
$2.37B
-90,990
SIX
3879
DELISTED
Six Flags Entertainment Corp.
SIX
-26,156
CEM
3880
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
-15,475
ENV
3881
DELISTED
ENVESTNET, INC.
ENV
-25,886
DIAL icon
3882
Columbia Diversified Fixed Income Allocation ETF
DIAL
$399M
-54,646
DNA icon
3883
Ginkgo Bioworks
DNA
$537M
-1,538
EB
3884
DELISTED
Eventbrite
EB
-40,816
EOD
3885
Allspring Global Dividend Opportunity Fund
EOD
$278M
-15,992
EVGO icon
3886
EVgo
EVGO
$300M
-13,842
EWA icon
3887
iShares MSCI Australia ETF
EWA
$1.4B
-9,832
UCTT
3888
Ultra Clean Holdings
UCTT
$3.68B
-4,514
SXC icon
3889
SunCoke Energy
SXC
$770M
-25,597
UOCT icon
3890
Innovator US Equity Ultra Buffer ETF October
UOCT
$180M
-8,175
INST
3891
DELISTED
Instructure Holdings, Inc.
INST
-10,243
FAM
3892
DELISTED
First Trust/abrdn Global Opportunity Income Fund
FAM
-57,553
GTHX
3893
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
-797,677
EGIO
3894
DELISTED
Edgio, Inc. Common Stock
EGIO
-11,044
ACI icon
3895
Albertsons Companies
ACI
$8.09B
-56,190
ACLS icon
3896
Axcelis
ACLS
$4.52B
-1,778
ADAP
3897
DELISTED
Adaptimmune Therapeutics
ADAP
-10,218
AFB
3898
AllianceBernstein National Municipal Income Fund
AFB
$319M
-10,894
AMTB icon
3899
Amerant Bancorp
AMTB
$897M
-9,505
ARQT icon
3900
Arcutis Biotherapeutics
ARQT
$2.66B
-21,631